Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Results from a 10-year study confirm that giving radiotherapy to women with early breast cancer in a lower overall dose through fewer, higher doses is at least as effective and safe as the current standard of a higher overall dose.
The finding comes from the UK Standardisation of Breast Radiotherapy (START) trials, results of which were recently published in The Lancet Oncology.
During the study, 4,451 women from 35 radiotherapy centers in the UK were recruited between 1999 and 2002 for two different subsets of the trial.
Each group compared different doses with the international standard, which is a total dose of 50 Gy - the unit of absorbed radiation - delivered in 25 small doses of 2 Gy over 5 weeks.
The two subsets were:
After 10 years, the tumor control rates of the women in START A were similar to both START B and the international standard. Very few women in START B experienced a relapse of their cancer, and they showed similar damage to surrounding healthy breast tissue.
Similarly, in START B, the number of women whose cancer returned was comparable after 10 years. However, the women in this group showed "significantly less harm" to the healthy breast tissue.
John Yarnold, study leader and professor from The Institute of Cancer Research, London, says:
"These 10-year results reassure us that 3 weeks of radiotherapy is as good as the 5 weeks still used in many countries, with less damage to nearby healthy tissue, as well as being more convenient for women (shorter waiting lists and fewer hospital visits) and cheaper for health services."
The researchers note that these outcomes were similar "irrespective of age, tumor grade, stage, chemotherapy use, or use of tumor bed boost."
Prof. Yarnold continues by saying "the upshot is that - contrary to conventional thinking - cancer cells are just as sensitive to the size of daily radiotherapy dose as the normal tissues responsible for late onset side effects."
This means that continuing to use the standard lower doses "spares the cancer as much as the healthy tissue," effectively offering no benefit to the patients.
Prof. Yarnold concludes:
"Our results support the continued use of 40 Gy in 15 fractions, which has already been adopted as the standard of care by most UK centers."
Written by Marie Ellis
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials John R Yarnold, et al., The Lancet Oncology, 19 September 2013.
Visit our Breast Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Ellis, Marie. "Shorter radiotherapy for early breast cancer 'best option'." Medical News Today. MediLexicon, Intl., 20 Sep. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/articles/266367>
Ellis, M. (2013, September 20). "Shorter radiotherapy for early breast cancer 'best option'." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/266367.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.